Medtronic Acquires SPR Therapeutics for $650 Million
Medical device company Medtronic has agreed to acquire SPR Therapeutics in a cash deal valued at approximately $650 million. The acquisition is expected to bolster Medtronic's neuromodulation business by adding peripheral nerve stimulation technology, which offers non-implantable treatment for chronic pain.
Tickers: $MDT